A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation

S. H. Lin, C. J. Cheng, Y. C. Lee, X. Ye, W. W. Tsai, J. Kim, R. Pasqualini, W. Arap, N. M. Navone, S. M. Tu, M. Hu, L. Y. Yu-Lee, C. J. Logothetis

研究成果: 雜誌貢獻文章同行評審

25 引文 斯高帕斯(Scopus)


ErbB3 is a transmembrane growth factor receptor that has been implicated in the pathogenesis of human cancer. After finding that a truncated form of ErbB3 was present and upregulated in metastatic prostate cancer cells in lymph nodes and bone, we explored the pathophysiological functions of this unusual form of ErbB3 in the context of mouse calvaria as well as osteoblasts in vitro and the femur microenvironment in vivo. Here we demonstrate that prostate cancer cells expressed an alternatively spliced transcript that encodes a 45-kDa glycosylated protein (p45-sErbB3). The recombinant p45-sErbB3 purified from conditioned medium stimulated calvarial bone formation and induced osteoblast differentiation. Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice. Further, we detected sErbB3 in plasma samples from patients with castration-resistant prostate cancer with bone metastasis. These observations establish that p45-sErbB3 is a structurally and functionally unique gene product of ErbB3 and suggest that p45-sErbB3 is likely one of the factors involved in the osteoblastic bone metastases of prostate cancer.

頁(從 - 到)5195-5203
出版狀態已發佈 - 9月 4 2008

ASJC Scopus subject areas

  • 分子生物學
  • 遺傳學
  • 癌症研究


深入研究「A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation」主題。共同形成了獨特的指紋。